Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,648.9
28.7 (1.10%)

 

  • STI Straits Times Index
    2,648.9
    28.7 (1.10%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,585.6
    -13.2 (-0.83%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,481.6
    3.7 (0.01%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,361.3
    -53.3 (-1.56%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,945.5
    358.5 (1.59%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,075.8
    -3.3 (-0.07%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,366.2M
  • Value: 1,138.6M
  • Rise: 196
  • Fall: 167
  • Unch: 447

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.176+0.007
IX Biopharma0.285-0.030
Biolidics0.435-0.085
Singapore-eDev0.091-0.011
Hyphens Pharma0.420-0.060
Clearbridge0.186-0.002
QT Vascular0.008-
Medtecs Intl0.645+0.010
Genting Sing0.785+0.010
Singtel2.540+0.020

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,265.5 -284.5
HSCEI 9,743.2 -110.0
Jakarta 4,863.1 -41.0
Nikkei 225 22,047.8 -464.2
SSE Comp 2,960.5 -10.1
Shanghai A 3,103.1 -10.6
Shanghai B 211.8 -1.7
KOSPI 2,097.3 -37.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

EQUILLIUM INC EQUILLIUM
Updated on 14 Jul 2020 (End of trading day)
Last (USD): 13.980 Change: -12.520 High: 19.180 Remarks: -
Change (%): -47.25 Low: 13.000
Open 19.120 Yesterday's Close 26.5
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 19,366,720 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.44764 Trailing EPS (USD) e -1.55434 NAV (USD) b 2.0553
PE a - Trailing PE f - Price / NAV b 6.8019
Dividend (USD) d - Cash In Hand (USD) g 1.1657 Issued & Paid-up Shares c 17,684,000
Dividend Yield (%) d - Price / Cash In Hand g 11.993 Treasury Shares h -
Market Cap (M) 247.222 Enterprise Value (M) 209.293
Piotroski F Score 0 Exchange Code EQ Par Value ( $ ) n.a.
52 Weeks Volatility (%) 91.18 Free Float (%) 35.9
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 19 May 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 05 Oct 2018.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference EQUILLIUM INC NASDAQ 247.222 - - 6.8019 -
Industry Biotechnology NASDAQ 3,008.637 375.077 6455.431 7.2664 0.634
Local Peer AMGEN INC NASDAQ 148,879.433 18.985 19.398 15.6963 2.304
Local Peer GILEAD SCIENCES INC NASDAQ 96,824.820 17.977 19.513 4.3878 3.295
Local Peer VERTEX PHARMACEUTICAL NASDAQ 76,183.361 64.737 50.421 11.7901 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 72,152.463 34.102 31.656 5.9468 -
Local Peer ILLUMINA INC NASDAQ 55,308.750 55.198 58.714 11.9329 -
Local Peer BIOGEN INC NASDAQ 45,899.607 7.795 7.808 3.6582 -
Local Peer SEATTLE GENETICS INC NASDAQ 30,021.080 - - 17.0031 -
Local Peer MODERNA INC NASDAQ 29,177.353 - - 17.7816 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 23,975.187 9.972 10.099 2.0408 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 22,863.222 - 200.544 7.0566 -
Local Peer INCYTE CORPORATION NASDAQ 22,393.766 50.108 - 11.5567 -
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 19,175.387 - - - -
Other Local Peers BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), IMMUNOMEDICS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), NOVAVAX INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), FIBROGEN INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), TG THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), VIELA BIO INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), UNIQURE N.V. (NASDAQ), XENCOR INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), VERACYTE INC (NASDAQ), REGENXBIO INC (NASDAQ), NANTKWEST INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), VAXCYTE INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), ARVINAS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), VAXART INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), COMPUGEN (NASDAQ), NKARTA INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), RETROPHIN INC (NASDAQ), PASSAGE BIO INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), KURA ONCOLOGY INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), PRECIGEN INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), IMMUNOGEN INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), IMMATICS N V (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), AKOUOS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), VANDA PHARMACE INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), AGENUS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), AVROBIO INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), ARDELYX INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), ATHERSYS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), PROTHENA CORP PLC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), PERSONALIS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), XBIOTECH INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), MERUS B V (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), KAMADA (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), IVERIC BIO INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), MANNKIND CORPORATION (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), AFFIMED N V (NASDAQ), PDL BIOPHARMA INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), IMV INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), NEXTCURE INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), MEDICINOVA INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), CHIASMA INC (NASDAQ), VERASTEM INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), ADURO BIOTECH INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), XOMA CORP (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), OTONOMY INC (NASDAQ), CHIMERIX INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), TREVENA INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), INMUNE BIO INC (NASDAQ), ARAVIVE INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), BELLUS HEALTH INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), INFLARX N V (NASDAQ), ORGENESIS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), SAVARA INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), VACCINEX INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), RESTORBIO INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), SESEN BIO INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), COHBAR INC (NASDAQ), SYNLOGIC INC (NASDAQ), CURIS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), SOLIGENIX INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), BIONANO GENOMICS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ADVAXIS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), AIKIDO PHARMA INC (NASDAQ), BIOCARDIA INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), EVOGENE LTD (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), OCUGEN INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), PRECIPIO INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SENESTECH INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ)
Global Peer CSL ASX 130,461.899 48.627 45.037 15.0851 0.923
Global Peer AMGEN-T HKEx 588,247.000 9.574 9.804 8.0015 4.569
Global Peer AGILENT TECHNOLOGIES INC NYSE 28,002.986 26.147 41.000 5.8731 0.724
Global Peer WUXI BIO HKEx 199,451.339 173.500 173.501 13.9471 -
Global Peer SINO BIOPHARM HKEx 189,609.757 61.776 62.342 5.4726 0.529
Global Peer BEIGENE HKEx 149,728.920 - - 6.8692 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 5,067.671 92.985 74.415 4.7150 -
Global Peer Lonza SGX 5,937.453 6.613 6.613 0.6568 4.787
Global Peer 3SBIO HKEx 33,356.284 30.211 30.211 3.0982 -
Global Peer GENSCRIPT BIO HKEx 30,744.219 - - 10.3072 -
Other Global Peers HAOHAI BIOTEC (HKEx), VIVA BIOTECH (HKEx), ALPHAMAB-B (HKEx), MYOVANT SCIENCES LTD (NYSE), ARCUS BIOSCIENCES INC (NYSE), MESOBLAST LTD (ASX), FRONTAGE (HKEx), POLYNOVO LIMITED (ASX), ASCENTAGE-B (HKEx), KINTOR PHARMA-B (HKEx), KADMON HLDGS INC (NYSE), ASCLETIS-B (HKEx), SINOMAB BIO-B (HKEx), LEE'S PHARM (HKEx), NANOVIRICIDES INC (NYSE American), ESSEX BIO-TECH (HKEx), DPHARMA (Bursa), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), TELIX PHARMACEUTIC (ASX), IBIO INC (NYSE American), PFENEX INC (NYSE American), NEXT SCIENCE LTD (ASX), CEL-SCI CORP (NYSE American), ENZO BIOCHEM INC (NYSE), LINEAGE CELL THERAPEUTICS INC (NYSE American), UNI-BIO GROUP (HKEx), IMUGENE LIMITED (ASX), NEUREN PHARMACEUTICALS LTD (ASX), AIM IMMUNOTECH INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), SYNTHETIC BIOLOGICS INC (NYSE American), INVEX THERAPEUTICS LTD NPV (ASX), CYNATA THERAPEUTICS LTD (ASX), IMMUTEP LTD (ASX), BIOTRON (ASX), MEMPHASYS LTD (ASX), ORAGENICS INC (NYSE American), CT ENTERPRISE (HKEx), BIOSINO BIO-TEC (HKEx), GENETIC TECHNOLOGIES (ASX), KAZIA THERAPEUTICS LIMITED (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), ALTERITY THERAPEUTICS LIMITED (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), BIONOMICS LTD (ASX), ANTEOTECH LIMITED (ASX), Suntar Eco-City (SGX), REGENT PACIFIC (HKEx), NOVABAY PHARMACEUTICALS INC (NYSE American), SIENNA CANCER DIAGNOSTICS LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), REGENEUS LTD (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), HOLISTA COLLTECH LIMITED (ASX), PATRYS LIMITED (ASX), RHINOMED LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), ADALTA LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), ANATARA LIFESCIENCES LTD (ASX), CRYOSITE (ASX), LEAF RESOURCES LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), NANOLLOSE LTD (ASX), HAO WEN HLDGS (HKEx)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+11.180
+399.29 %
10 Days -+11.180
+399.29 %
20 Days -+11.260
+413.97 %
Medium Term Return 3 Months -+11.480
+459.20 %
6 Months -+9.470
+209.98 %
1 Year -+8.480
+154.18 %
Annualised Return Annualised --
+154.18 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 2.200 - 27.050 Change From 1 Year Low +11.780 % Change From 1 Year Low (%) +535.45
Change From 1 Year High -13.070 % Change From 1 Year High (%) -48.32
2 Years Range 2.200 - 27.050 Change From 2 Years Low +11.780 % Change From 2 Years Low (%) +535.45
Change From 2 Years High -13.070 % Change From 2 Years High (%) -48.32
5 Years Range 2.200 - 27.050 Change From 5 Years Low +11.780 % Change From 5 Years Low (%) +535.45
Change From 5 Years High -13.070 % Change From 5 Years High (%) -48.32
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Equillium, Inc. is a biotechnology company, which engages in the development of products for severe immuno-inflammatory disorders with high unmet medical need. Its product pipeline includes EQ001, which is a monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. The company was founded by Daniel Mark Bradbury, Bruce D. Steel, and Stephen Connelly on March 16, 2017 and is headquartered in La Jolla, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
14 Jul 2020 19.120 19.180 13.000 13.980 19,366,720 -
13 Jul 2020 9.000 27.050 7.350 26.500 99,684,630 -
10 Jul 2020 3.430 3.430 3.020 3.190 48,232 -
09 Jul 2020 2.970 3.380 2.880 3.316 167,456 -
08 Jul 2020 2.830 2.830 2.680 2.800 25,449 -
07 Jul 2020 2.784 2.840 2.640 2.830 67,364 -
06 Jul 2020 2.850 2.900 2.730 2.825 21,055 -
02 Jul 2020 2.792 2.820 2.711 2.780 25,260 -
01 Jul 2020 2.870 2.890 2.800 2.800 20,626 -
30 Jun 2020 2.850 2.950 2.820 2.950 18,452 -
29 Jun 2020 3.000 3.000 2.760 2.830 21,534 -
26 Jun 2020 2.710 2.900 2.680 2.880 126,878 -
25 Jun 2020 2.640 2.850 2.640 2.700 128,192 -
24 Jun 2020 2.660 2.749 2.530 2.690 141,787 -
23 Jun 2020 2.650 2.700 2.630 2.630 59,223 -
22 Jun 2020 2.800 2.850 2.620 2.620 34,843 -
19 Jun 2020 2.700 2.900 2.693 2.730 25,736 -
18 Jun 2020 2.750 2.900 2.750 2.760 23,973 -
17 Jun 2020 2.890 2.980 2.640 2.720 10,791 -
16 Jun 2020 2.800 2.990 2.777 2.870 39,915 -
15 Jun 2020 2.850 2.920 2.600 2.890 39,913 -
12 Jun 2020 2.820 2.830 2.550 2.690 21,450 -
Summary
Current 2 Weeks
(30 Jun 2020 to 14 Jul 2020)
2.850 27.050 2.640 13.980 119,445,244 -
Previous 2 Weeks
(16 Jun 2020 to 29 Jun 2020)
2.800 27.050 2.640 2.830 612,872 -
4 Weeks from
(18 May 2020 to 15 Jun 2020)
2.980 27.050 2.630 2.890 558,622 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.